Published in Ann Rheum Dis on January 01, 1997
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis (2004) 1.58
HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev (2004) 1.32
When is arthritis reactive? Postgrad Med J (2006) 0.87
Treating reactive arthritis: insights for the clinician. Ther Adv Musculoskelet Dis (2010) 0.83
Outcome of reactive arthritis after an extensive Finnish waterborne gastroenteritis outbreak: a 1-year prospective follow-up study. Clin Rheumatol (2013) 0.83
The role of intracellular organisms in the pathogenesis of inflammatory arthritis. Int J Inflam (2014) 0.78
Successful use of etanercept for the treatment of Reiter's syndrome: a case report and review of the literature. Rheumatol Int (2011) 0.78
The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. Int J Clin Rheumtol (2012) 0.78
Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis. Best Pract Res Clin Rheumatol (2014) 0.78
Work-related outcomes in randomised placebo-controlled pain trials: a systematic review and meta-analysis. J Occup Med Toxicol (2014) 0.75
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum (1991) 11.66
Sulphasalazine in rheumatoid arthritis. Br Med J (1980) 3.53
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol (1991) 1.45
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med (1984) 1.42
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30
HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. J Rheumatol (1985) 1.23
HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis. J Rheumatol (1985) 0.96
Repeat ileocolonoscopy in reactive arthritis. J Rheumatol (1987) 0.94
Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol (1986) 0.90
Evaluation of sulphasalazine in the treatment of spondyloarthropathies. Ann Rheum Dis (1992) 0.83
[Therapy of seronegative oligoarthritis with salazopyrine]. Z Rheumatol (1987) 0.80
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med (2000) 16.20
PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature (1993) 8.83
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet (1997) 6.71
The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer (1997) 5.01
Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol (1994) 3.50
A natural language parsing system for encoding admitting diagnoses. Proc AMIA Annu Fall Symp (1997) 2.34
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Efficient pH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA. Nucleic Acids Res (1995) 2.07
The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum (2000) 1.97
Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis. Ann Rheum Dis (1987) 1.91
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis (2008) 1.71
Defining incident vertebral deformity: a prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1999) 1.55
The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis (2008) 1.55
The EWS/FLI1 oncogenic transcription factor deregulates GLI1. Oncogene (2007) 1.53
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Ann Rheum Dis (2013) 1.53
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Ann Rheum Dis (2014) 1.52
CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol (1998) 1.50
Effect of different stocking densities during transport on welfare and meat quality in Danish slaughter pigs. Meat Sci (1998) 1.48
Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides. J Natl Cancer Inst (1997) 1.47
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest (1995) 1.44
The continuing challenge of predictive factors in rheumatoid arthritis: prediction or association? J Rheumatol (1997) 1.43
Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer (1999) 1.40
Mental health services for HIV/AIDS patients are long overdue. S Afr Med J (2009) 1.40
Medication management. Hosp Community Psychiatry (1990) 1.37
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks. Ann Rheum Dis (2005) 1.35
The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol (1993) 1.33
Activin is an essential early mesenchymal signal in tooth development that is required for patterning of the murine dentition. Genes Dev (1998) 1.30
Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital x ray radiogrammetry than dual x ray absorptiometry: relationship with disease activity and radiographic outcome. Ann Rheum Dis (2004) 1.28
Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest (1990) 1.28
Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut (1987) 1.26
Increased DNA binding and sequence discrimination of PNA oligomers containing 2,6-diaminopurine. Nucleic Acids Res (1997) 1.25
Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol (1983) 1.25
Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol (2001) 1.24
The original "DAS" and the "DAS28" are not interchangeable: comment on the articles by Prevoo et al. Arthritis Rheum (1998) 1.21
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis. Ann Rheum Dis (2007) 1.20
Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol (2000) 1.20
Adaptation into Danish of the Stanford Health Assessment Questionnaire (HAQ) and the Rheumatoid Arthritis Quality of Life Scale (RAQoL). Scand J Rheumatol (2001) 1.19
Angio-tumoral complex in human malignant melanoma characterised by free laminin: ultrastructural and immunohistochemical observations. J Submicrosc Cytol Pathol (1997) 1.19
Persistence of a Salmonella enterica serovar typhimurium DT12 clone in a piggery and in agricultural soil amended with Salmonella-contaminated slurry. Appl Environ Microbiol (2001) 1.18
Joint consultation of general practitioner and rheumatologist: does it matter? Ann Rheum Dis (2003) 1.17
Hybridization of peptide nucleic acid. Biochemistry (1998) 1.16
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol (1999) 1.15
Gene targeting approaches using positive-negative selection and large flanking regions. Plant Mol Biol (1997) 1.14
Symptom-giving pelvic girdle relaxation in pregnancy. I: Prevalence and risk factors. Acta Obstet Gynecol Scand (1999) 1.14
Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up. Lancet (1990) 1.09
Angio-tumoral laminin in murine tumors derived from human melanoma cell lines. Immunohistochemical and ultrastructural observations. J Submicrosc Cytol Pathol (1998) 1.08
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum (2000) 1.07
Myofibrosarcoma of subcutaneous soft tissue of the cheek. J Submicrosc Cytol Pathol (1992) 1.06
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol (1998) 1.05
Myofibrosarcoma of the breast: review of the literature on myofibroblastic tumors and criteria for defining myofibroblastic differentiation. Am J Surg Pathol (1997) 1.05
Typologies of caregiving families: family congruence and individual well-being. Gerontologist (1997) 1.05
Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status. Ann Rheum Dis (1990) 1.05
Can we predict aggressive disease? Baillieres Clin Rheumatol (1997) 1.04
Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma. Cancer (1986) 1.04
Short-term reproducibility of computed tomography-based lung density measurements in alpha-1 antitrypsin deficiency and smokers with emphysema. Acta Radiol (2004) 1.04
Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol (2008) 1.03
A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects. Ann Rheum Dis (1999) 1.03
Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing. Ann Rheum Dis (2008) 1.03
Clinical synovitis and radiological lesions in rheumatoid arthritis. A prospective study of 25 patients during treatment with remission-inducing drugs. Scand J Rheumatol (1983) 1.03
Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion (1997) 1.03
Symptom-giving pelvic girdle relaxation in pregnancy. II: Symptoms and clinical signs. Acta Obstet Gynecol Scand (1999) 1.02
Severe dermatomyositis treated with cyclosporin A. Ann Rheum Dis (1986) 1.02
Comparison of dual X-ray absorptiometry (DXA), digital X-ray radiogrammetry (DXR), and conventional radiographs in the evaluation of osteoporosis and bone erosions in patients with rheumatoid arthritis. Scand J Rheumatol (2005) 1.02
Cystosarcoma phyllodes. A review of 19 cases with emphasis on the occurrence of associated breast carcinoma. Acta Pathol Microbiol Immunol Scand A (1986) 1.01
Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut (1999) 1.00
P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis. Oncogene (2008) 1.00
Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database. Scand J Rheumatol (2007) 0.99
Pathogenesis of primary shallow chamber angle closure glaucoma. Arch Ophthalmol (1966) 0.97
Type-1 plasminogen activator inhibitor in human breast carcinomas. Int J Cancer (1992) 0.97
Histologic changes and silicone concentrations in human breast tissue surrounding silicone breast prostheses. Plast Reconstr Surg (1990) 0.95
Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis. Ann Rheum Dis (2006) 0.95
Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO). Scand J Rheumatol (2005) 0.94
Treatment of rheumatoid arthritis with prostaglandin E1 precursors cis-linoleic acid and gamma-linolenic acid. Scand J Rheumatol (1983) 0.93
Understanding the well-being of care receivers. Gerontologist (1997) 0.92
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol (1998) 0.92
Oxygen affinity of haemoglobin and red cell 2,3-diphosphoglycerate in childhood diabetes. Acta Paediatr Scand (1975) 0.91
The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur J Clin Invest (1992) 0.91
Postoperative shallowing of the anterior chamber. Am J Ophthalmol (1967) 0.90
Information transfer from DNA to peptide nucleic acids by template-directed syntheses. Nucleic Acids Res (1997) 0.89
Assessing radiographic status of rheumatoid arthritis: introduction of a short erosion scale. J Rheumatol (2000) 0.89
Endoscopic evaluation of the effect of indomethacin capsules and suppositories on the gastric mucosa in rheumatic patients. J Rheumatol (1984) 0.89
Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent. Ann Rheum Dis (1985) 0.88
The half-lap incision and closure in cataract surgery. Am J Ophthalmol (1966) 0.87
A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblasts. Eur J Biochem (1991) 0.87
Ectopic production of intact parathyroid hormone by a squamous cell lung carcinoma in vivo and in vitro. J Clin Endocrinol Metab (1996) 0.87
Rapid automated synthesis via diisopropyl phosphoramidite in situ activation. Chemical synthesis and cloning of a calmodulin gene. Biochem Cell Biol (1986) 0.87
Histochemistry and acetylcholine receptor distribution in normal and denervated monkey extraocular muscles. Neurology (1978) 0.87
Radiographic progression in rheumatoid arthritis: results of 3 comparative trials. J Rheumatol (1995) 0.87
Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge. Avian Dis (1996) 0.86
Antikeratin antibodies in synovial fluid in rheumatoid arthritis. APMIS (1989) 0.86
Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. Scand J Rheumatol (2007) 0.86
Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Scand J Rheumatol (1992) 0.86
Isolated capitate fracture diagnosed by computed tomography. Case report. Handchir Mikrochir Plast Chir (1999) 0.86
Ultrastructural and immunohistochemical studies of the periendothelial matrix in human melanoma: evidence for an amorphous matrix containing laminin. J Cutan Pathol (1999) 0.86
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial. Ann Rheum Dis (2013) 0.86
Clinical examination of pelvic insufficiency during pregnancy. An evaluation of the interobserver variation, the relation between clinical signs and pain and the relation between clinical signs and physical disability. Scand J Rheumatol (1994) 0.85